The Service Line

Enforcement: CVS’s Omnicare exit starts a 14-day clock on a $130 million payment to the Justice Department

Omnicare’s Chapter 11 plan, confirmed September 17, is set to take effect this month, and the day it does CVS has two weeks to wire the first $130 million of a $440 million False Claims Act settlement. Judge Stacey Jernigan of the Northern District of Texas bankruptcy court signed off on the plan almost a year after the long term care pharmacy filed, according to Healthcare Dive. The remaining $310 million is due by March 15, 2028, with CVS guaranteeing it if Omnicare’s estate cannot pay. The settlement resolves a judgment of roughly $950 million over long term care dispensing without valid prescriptions, carries no admission of wrongdoing, and the plan is built around Omnicare’s $250 million sale to GenieRx. For any pharmacy that serves nursing homes, this is the clearest price tag yet on dispensing without a valid prescription on file. Confidence: High on the amounts and confirmation, Medium on the exact effective date, which was described only as “October” by Omnicare’s counsel in secondary reporting.

Reimbursement: A dozen Arkansas pharmacies are testing whether a state price floor can actually be enforced

Twelve independent Arkansas pharmacies sued Express Scripts on September 15, alleging it paid them below the state’s National Average Drug Acquisition Cost (NADAC) floor “not less than tens of thousands of times” between August 2025 and March 2026. The complaint, filed in St. Louis County, Missouri, is the first brought under Arkansas Act 990, which gives pharmacies a private right to sue, according to Healthcare Dive. Plaintiffs’ lawyers say damages could reach hundreds of millions of dollars, though reports disagree on the figure and none of it is adjudicated. Express Scripts says it will defend itself. If the theory holds, every state with a reimbursement floor becomes a claims audit your pharmacy can run on its own remittances. Confidence: Medium, early-stage allegations.

Who’s Buying: Three PBM giants are suing Tennessee to keep the pharmacies they own

CVS Caremark, Express Scripts and the Pharmaceutical Care Management Association have each sued to block Tennessee’s law barring a company from owning both a health insurer or pharmacy benefit manager and a pharmacy. The law takes effect July 1, 2028, and CVS says it would have to close 136 retail and specialty pharmacies and halt mail order in the state, per Tennessee Lookout. Express Scripts argues the law is preempted by federal programs including ERISA, TRICARE and Medicare Part D. Arkansas’s similar ban remains blocked by a federal district court, and no ruling on the appeal has appeared in the sources we reviewed. Operators negotiating network or sale terms should assume the vertical integration question stays unsettled through at least 2028. Confidence: Medium on timing, no hearing dates found.

Clinical Policy: Independents are filling more weight-loss GLP-1s, and that is where the volume is

IQVIA’s Scott Biggs told the PBMI conference that 35% of independent pharmacies now decline to fill weight-loss GLP-1 prescriptions, down from 48.5% a year ago. The numbers behind that shift, reported by Managed Healthcare Executive: weight-loss GLP-1 sales are up 75% year over year to $55 billion over 12 months, nearly half of all prescription sales growth comes from GLP-1s, and about 80% of GLP-1 sales run through retail pharmacies. The Medicare GLP-1 Bridge paid 9,000 claims in its first three days, roughly $2 million by Biggs’s estimate. A pharmacy that still refuses these scripts is declining the single largest growth line in the building. Confidence: Medium, conference remarks, not a published dataset.

The Operator Metric: 65,795

Independent pharmacies filled an average of 65,795 prescriptions per store in 2025, down from 67,601 in 2024, even as the store count held at an estimated 18,988. Both figures come from the National Community Pharmacists Association’s 2026 Digest, released October 4, summarized by Pharmacy Times. The count is essentially flat against 18,960 a year earlier, which again undercuts the “one closure a day” framing, but volume per store fell about 2.7%. Government programs account for nearly half of all prescriptions, and 81% are generic, so a few cents of reimbursement on a fixed volume moves the whole margin. Track your own scripts per day against this benchmark, and read it next to your payer mix. Confidence: High on the Digest figures.